Clinical Implications of Hepatocyte Growth Factor, Interleukin-20, and Interleukin-22 in Serum and Bronchoalveolar Fluid of Patients with Non-Small Cell Lung Cancer.
about
Hepatocyte growth factor is a prognostic marker in patients with colorectal cancer: a meta-analysis.Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer.Effectiveness of Bronchofiberoscopy in Diagnosis of Lung Lesions.Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers
P2860
Clinical Implications of Hepatocyte Growth Factor, Interleukin-20, and Interleukin-22 in Serum and Bronchoalveolar Fluid of Patients with Non-Small Cell Lung Cancer.
description
2016 nî lūn-bûn
@nan
2016 թվականի օգոստոսի 30-ին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Clinical Implications of Hepat ...... th Non-Small Cell Lung Cancer.
@en
Clinical Implications of Hepat ...... th Non-Small Cell Lung Cancer.
@nl
type
label
Clinical Implications of Hepat ...... th Non-Small Cell Lung Cancer.
@en
Clinical Implications of Hepat ...... th Non-Small Cell Lung Cancer.
@nl
prefLabel
Clinical Implications of Hepat ...... th Non-Small Cell Lung Cancer.
@en
Clinical Implications of Hepat ...... th Non-Small Cell Lung Cancer.
@nl
P2860
P50
P356
P1476
Clinical Implications of Hepat ...... th Non-Small Cell Lung Cancer.
@en
P2093
E Chyczewska
M Ossolińska
P2860
P356
10.1007/5584_2016_66
P407
P577
2016-08-30T00:00:00Z